| Palbociclib | Approved Investigational | CENPE | 1062 |
downregulated | palbociclib results in decreased expression of CENPE mRNA | 4q24 | |
| Palbociclib | Approved Investigational | CENPF | 1063 |
downregulated | palbociclib results in decreased expression of CENPF mRNA | 1q41 | |
| Palbociclib | Approved Investigational | CENPM | 79019 |
downregulated | palbociclib results in decreased expression of CENPM mRNA | 22q13.2 | |
| Palbociclib | Approved Investigational | CEP55 | 55165 |
downregulated | palbociclib results in decreased expression of CEP55 mRNA | 10q23.33 | |
| Palbociclib | Approved Investigational | CKAP2L | 150468 |
downregulated | palbociclib results in decreased expression of CKAP2L mRNA | 2q14.1 | |
| Palbociclib | Approved Investigational | CPA4 | 51200 |
upregulated | palbociclib results in increased expression of CPA4 mRNA | 7q32.2 | |
| Palbociclib | Approved Investigational | CYR61 | 3491 |
upregulated | palbociclib results in increased expression of CYR61 mRNA | 1p22.3 | |
| Palbociclib | Approved Investigational | DENND6B | 414918 |
upregulated | palbociclib results in increased expression of DENND6B mRNA | 22q13.33 | |
| Palbociclib | Approved Investigational | DEPDC1B | 55789 |
downregulated | palbociclib results in decreased expression of DEPDC1B mRNA | 5q12.1 | |
| Palbociclib | Approved Investigational | DHFRP2 | 729816 |
downregulated | palbociclib results in decreased expression of DHFRP2 mRNA | 6p21.33 | |
| Palbociclib | Approved Investigational | DLGAP5 | 9787 |
downregulated | palbociclib results in decreased expression of DLGAP5 mRNA | 14q22.3 | |
| Palbociclib | Approved Investigational | DONSON | 29980 |
downregulated | palbociclib results in decreased expression of DONSON mRNA | 21q22.11 | |
| Palbociclib | Approved Investigational | E2F2 | 1870 |
downregulated | palbociclib results in decreased expression of E2F2 mRNA | 1p36.12 | |
| Palbociclib | Approved Investigational | EXO1 | 9156 |
downregulated | palbociclib results in decreased expression of EXO1 mRNA | 1q43 | |
| Palbociclib | Approved Investigational | EZH2 | 2146 |
downregulated | palbociclib results in decreased expression of EZH2 mRNA | 7q36.1 | |
| Palbociclib | Approved Investigational | F3 | 2152 |
upregulated | palbociclib results in increased expression of F3 mRNA | 1p21.3 | |
| Palbociclib | Approved Investigational | FAM111A | 63901 |
downregulated | palbociclib results in decreased expression of FAM111A mRNA | 11q12.1 | |
| Palbociclib | Approved Investigational | FAM83D | 81610 |
downregulated | palbociclib results in decreased expression of FAM83D mRNA | 20q11.23 | |
| Palbociclib | Approved Investigational | FANCI | 55215 |
downregulated | palbociclib results in decreased expression of FANCI mRNA | 15q26.1 | |
| Palbociclib | Approved Investigational | FBXO5 | 26271 |
downregulated | palbociclib results in decreased expression of FBXO5 mRNA | 6q25.2 | |
| Palbociclib | Approved Investigational | FEN1 | 2237 |
downregulated | palbociclib results in decreased expression of FEN1 mRNA | 11q12.2 | |
| Palbociclib | Approved Investigational | FOXM1 | 2305 |
downregulated | palbociclib results in decreased expression of FOXM1 mRNA | 12p13.33 | |
| Palbociclib | Approved Investigational | GINS2 | 51659 |
downregulated | palbociclib results in decreased expression of GINS2 mRNA | 16q24.1 | |
| Palbociclib | Approved Investigational | GMNN | 51053 |
downregulated | palbociclib results in decreased expression of GMNN mRNA | 6p22.3 | |
| Palbociclib | Approved Investigational | GPSM2 | 29899 |
downregulated | palbociclib results in decreased expression of GPSM2 mRNA | 1p13.3 | |